Form 4: Hartford CFO Exercises Options, Sells Shares
Insider Transaction Report
Hartford Insurance Group's EVP and CFO, Beth Ann Costello, exercised stock options and subsequently sold a portion of her common stock holdings on January 2, 2026, under a pre-arranged 10b5-1 trading plan.
Summary
- Beth Ann Costello, Executive Vice President and Chief Financial Officer of Hartford Insurance Group, Inc. (HIG), reported transactions on January 2, 2026.
- Ms. Costello acquired 35,339 shares of common stock by exercising stock options at a price of $48.89 per share.
- She then disposed of 11,368 shares of common stock at a weighted average sale price of $137.037 per share, with individual sales ranging from $136.90 to $137.19.
- An additional 23,971 shares of common stock were sold at a weighted average price of $136.3704 per share, with individual sales ranging from $135.90 to $136.90.
- All reported transactions were conducted pursuant to a Rule 10b5-1 trading plan that Ms. Costello adopted on August 4, 2025.
- Following these transactions, Ms. Costello directly beneficially owns 77,573.606 shares of Hartford Insurance Group common stock.
- She also holds various unexercised stock options with exercise prices ranging from $49.01 to $116.41, and expiration dates extending up to February 25, 2035.
Sentiment
Score: 6
Explanation: The filing reports a profitable, pre-planned insider transaction, which is a neutral to slightly positive signal. It reflects past stock appreciation and transparent executive compensation practices, without indicating any new fundamental changes to the company's outlook.
Positives
- The exercise of stock options at $48.89 and subsequent sale at an average price of approximately $137 indicates a significant profit for the executive, reflecting strong past performance and appreciation of the company's stock.
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which enhances transparency and suggests a planned, non-opportunistic approach to insider trading.
Industry Context
Insider transactions, particularly those involving the exercise of stock options and subsequent sale of shares, are common occurrences in publicly traded companies across all industries, including the insurance sector. These transactions often reflect executive compensation structures and personal financial planning rather than a direct signal about the company's immediate future performance, especially when conducted under a pre-arranged 10b5-1 plan.
Stakeholder Impact
- Shareholders: Provides transparency regarding executive stock ownership and compensation. The profitable nature of the option exercise could be viewed positively as it reflects past stock price growth, but the sale itself is a routine event for executives managing their equity holdings.
- Employees: No direct impact on employees is indicated by this filing.
- Customers: No direct impact on customers is indicated by this filing.
- Suppliers: No direct impact on suppliers is indicated by this filing.
- Creditors: No direct impact on creditors is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| February 28, 2020 | Options with an exercise price of $48.89 became fully exercisable. |
| February 27, 2021 | Options with an exercise price of $53.81 became fully exercisable. |
| February 26, 2022 | Options with an exercise price of $49.01 became fully exercisable. |
| February 25, 2023 | Options with an exercise price of $55.27 became fully exercisable. |
| February 23, 2024 | Options with an exercise price of $51.87 became fully exercisable. |
| February 28, 2024 | One-third of options with an exercise price of $78.28 became exercisable. |
| August 4, 2025 | Rule 10b5-1 trading plan was adopted by Ms. Costello. |
| February 23, 2025 | Options with an exercise price of $69.41 became fully exercisable. |
| February 27, 2025 | One-third of options with an exercise price of $95.74 became exercisable. |
| February 28, 2025 | An additional one-third of options with an exercise price of $78.28 became exercisable. |
| January 2, 2026 | Date of reported stock option exercise and common stock sales. |
| February 25, 2026 | One-third of options with an exercise price of $116.41 will become exercisable. |
| February 27, 2026 | An additional one-third of options with an exercise price of $95.74 will become exercisable. |
| February 28, 2026 | The remaining one-third of options with an exercise price of $78.28 will become exercisable. |
| February 27, 2027 | The remaining one-third of options with an exercise price of $95.74 will become exercisable. |
| February 28, 2027 | Expiration date for options with an exercise price of $48.89. |
| February 25, 2027 | An additional one-third of options with an exercise price of $116.41 will become exercisable. |
| February 27, 2028 | The remaining one-third of options with an exercise price of $116.41 will become exercisable. |
| February 27, 2028 | Expiration date for options with an exercise price of $53.81. |
| February 26, 2029 | Expiration date for options with an exercise price of $49.01. |
| February 25, 2030 | Expiration date for options with an exercise price of $55.27. |
| February 23, 2031 | Expiration date for options with an exercise price of $51.87. |
| February 23, 2032 | Expiration date for options with an exercise price of $69.41. |
| February 28, 2033 | Expiration date for options with an exercise price of $78.28. |
| February 27, 2034 | Expiration date for options with an exercise price of $95.74. |
| February 25, 2035 | Expiration date for options with an exercise price of $116.41. |
Recommendation
holdThis Form 4 filing details a routine, pre-planned insider transaction by a key executive, involving the exercise of stock options and subsequent sale of shares. While the transaction was profitable for the executive, reflecting past stock performance, it does not provide new fundamental information about Hartford Insurance Group's operational performance, strategic direction, or future prospects that would warrant a change in investment recommendation. Such transactions are typically part of executive compensation and personal financial management, especially when conducted under a 10b5-1 plan, and are generally not considered a strong buy or sell signal.
Keywords
Hartford Insurance Group, HIG, Beth Ann Costello, CFO, insider trading, Form 4, stock options, equity sales, 10b5-1 plan, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.